Header Logo

Connection

Lerato Mohapi to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Lerato Mohapi has written about HIV Integrase Inhibitors.
Lerato Mohapi
Connection Strength
0,120
HIV Integrase Inhibitors
  1. Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection. PLoS One. 2015; 10(2):e0118228.
    View in: PubMed
    Score: 0,120
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.